Insmed Inc (NASDAQ: INSM) closed the day trading at $26.58 up 1.72% from the previous closing price of $26.13. In other words, the price has increased by $+0.45 from its previous closing price. On the day, 1094720 shares were traded.
Ratios:
For a better understanding of INSM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.75 and its Current Ratio is at 4.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wolfe Research on February 15, 2024, initiated with a Outperform rating and assigned the stock a target price of $42.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $55.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 12 ’24 when Adsett Roger sold 5,251 shares for $28.63 per share. The transaction valued at 150,336 led to the insider holds 148,559 shares of the business.
Flammer Martina M.D. sold 4,667 shares of INSM for $133,616 on Jan 12 ’24. The Chief Medical Officer now owns 106,898 shares after completing the transaction at $28.63 per share. On Jan 10 ’24, another insider, Adsett Roger, who serves as the Chief Operating Officer of the company, sold 3,536 shares for $28.90 each. As a result, the insider received 102,190 and left with 153,810 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSM now has a Market Capitalization of 3.94B and an Enterprise Value of 4.37B. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.93. Its current Enterprise Value per Revenue stands at 14.31 whereas that against EBITDA is -6.62.
Stock Price History:
Over the past 52 weeks, INSM has reached a high of $32.00, while it has fallen to a 52-week low of $16.04. The 50-Day Moving Average of the stock is 27.98, while the 200-Day Moving Average is calculated to be 25.00.
Shares Statistics:
Over the past 3-months, INSM traded about 1.66M shares per day on average, while over the past 10 days, INSM traded about 1.61M shares per day. A total of 147.98M shares are outstanding, with a floating share count of 144.65M. Insiders hold about 2.59% of the company’s shares, while institutions hold 101.40% stake in the company. Shares short for INSM as of Feb 29, 2024 were 8.57M with a Short Ratio of 5.17, compared to 10.39M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.77% and a Short% of Float of 5.86%.
Earnings Estimates
Current recommendations for the stock of the company come from 14 analysts. On average, analysts expect EPS of -$1.23 for the current quarter, with a high estimate of -$1.11 and a low estimate of -$1.38, while EPS last year was -$1.17. The consensus estimate for the next quarter is -$1.13, with high estimates of -$0.9 and low estimates of -$1.42.
Analysts are recommending an EPS of between -$3.71 and -$5.26 for the fiscal current year, implying an average EPS of -$4.6. EPS for the following year is -$3.8, with 15 analysts recommending between -$2.86 and -$5.57.
Revenue Estimates
11 analysts predict $78.58M in revenue for the current quarter. It ranges from a high estimate of $86.2M to a low estimate of $73.7M. As of the current estimate, Insmed Inc’s year-ago sales were $64.51M, an estimated increase of 21.80% from the year-ago figure. For the next quarter, 11 analysts are estimating revenue of $88.37M, an increase of 14.40% less than the figure of $21.80% in the same quarter last year. There is a high estimate of $92.44M for the next quarter, whereas the lowest estimate is $84.9M.
A total of 14 analysts have provided revenue estimates for INSM’s current fiscal year. The highest revenue estimate was $377.25M, while the lowest revenue estimate was $343.7M, resulting in an average revenue estimate of $356M. In the same quarter a year ago, actual revenue was $305.21M, up 16.60% from the average estimate. Based on 15 analysts’ estimates, the company’s revenue will be $516.45M in the next fiscal year. The high estimate is $615M and the low estimate is $422.99M. The average revenue growth estimate for next year is up 45.10% from the average revenue estimate for this year.
